Clinical Trial Update: Safety and Performance of MIRASOL® PRT Treated Platelet Transfusion Products [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 trial assessing the safety and performance of MIRASOL PRT treated platelet transfusion products. The study concerns patients with thrombocytope…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombocytopenia

Drugs mentioned

• MIRASOL PRT Treated Platelet Transfusion Products

Snippet

Sponsor: Terumo BCTbio | Conditions: Thrombocytopenia | EARLY_Phase 1 | Status: COMPLETED